NAMs and the Funding Frontier: How Modern Toxicology Maximizes Scientific Return on Investment
By Zachary Liebowitz | May 15th, 2025
“Funders are not only looking for scientific merit—they are also scrutinizing value and feasibility. NAMs answer all three.”
Image by ChatGPT
Advancing NAMs for Risk Assessment: Perspectives from SOT 2025
By Breanne Kincaid | April 17th, 2025
“Together, these presentations illustrate a clear shift towards integrated, mechanistically informed risk assessment strategies that reduce the number of animals required to generate toxicity data—paving the way for regulatory frameworks that are both scientifically robust and economically sustainable.”
Image by Breanne Kincaid